NAD Recommends Goodnighties Discontinue All Claims at Issue in Consumer Challenge; Company Agrees to Do So

New York, NY – April 9, 2013 – The National Advertising Division has recommended that Goodnighties, Inc., discontinue certain advertising claims, including claims that the ionized fibers in the company’s sleepwear neutralize stress and that the company’s sleepwear “increases oxygen flow in blood cells to help rest, recover and restore tired achy muscles.”

NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus.

The claims at issue in NAD’s review – which appeared at the advertiser’s website, in press releases and at YouTube – were challenged by a consumer.
NAD requested substantiation for claims that included:

  •  “These jammies are made with a smart-fabric uniquely created to neutralize the stress our bodies produce.”
  •  “Wearing Goodnighties with Ionx close to the body has been proven to stimulate blood flow thus reducing inflammation, improving muscle function, speeding recovery and reducing muscle aches & pains.”
  •  “When worn, Goodnighties sleepwear increases oxygen flow in blood cells to help rest, recover and restore tired achy muscles. The end result being a more peaceful restorative sleep.”
  •  “You will enter a REM (Rapid Eye Movement) sleeping state quicker and stay there longer allowing you to wake refreshed and ready to brave the day!”
  •  “Goodnighties is the most advanced sleepwear on the market . . .”

NAD also examined whether the claims at issue implied that wearing Goodnighties would help consumers who suffer from Fibromyalgia.

Goodnighties products are made from IonX fabric, which has been treated with negatively charged ions.

NAD noted in its decision that the advertiser did not provide competent and reliable scientific evidence in support of its claims. As a result, NAD recommended that the advertiser discontinue all “clinically proven” and health-performance claims that reference the purported effect of negative ions on the wearer.

Such claims include, for example, that the ionized fibers (IonX) in the sleepwear neutralize stress, stimulate blood flow, reduce inflammation, improve muscle function, speed recovery, reduce muscle aches and pains, provide a more restful sleep, provide relief from Fibromyalgia, night sweats and hot flashes, and provide the same benefits as those received by professional athletes who have worn IonX to help restore strained muscles.

Further, in the absence of any comparative performance testing between Goodnighties and its competitors, NAD recommended modification of the phrase “the most advanced” sleepwear on the market to instead state “one of the most advanced.”

Goodnighties, in its advertiser’s statement, said it “agrees with NAD’s recommendations and will make the necessary changes to its advertising. Further, Goodnighties intends to embark on a double blind sleep study in order to support certain claims with scientific fact. Goodnighties thanks NAD for its assistance in this matter.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Oral Essentials Discontinue "Certified Non-Toxic" Claim for its Lumineux Mouthwash

New York, NY – December 30, 2024 – In a Fast-Track SWIFT challenge brought by GuruNanda, the National Advertising Division recommended that Oral Essentials discontinue its claim that Lumineux mouthwash products are “Certified Non-Toxic.” 

Read the Decision Summary
Decision

NARB Recommends T-Mobile Discontinue or Modify Commercial to Better Disclose Conditions of Free iPhone Offer, 20% Savings Claim

New York, NY – December 30, 2024 – A panel of the National Advertising Review Board (NARB) recommended that T-Mobile discontinue or modify its commercial to better disclose the material conditions of its free iPhone 16 Pro offer and its 20% rate plan savings claim compared to AT&T and Verizon. 

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims

McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action

McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.  

Read the Decision Summary